Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.96
+0.68 (12.49%)
Dec 27, 2024, 1:17 PM EST - Market open
Serina Therapeutics Employees
As of December 31, 2023, Serina Therapeutics had 11 total employees, including 9 full-time and 2 part-time employees.
Employees
11
Change
n/a
Growth
n/a
Revenue / Employee
$287,045
Profits / Employee
-$668,104
Market Cap
55.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Singular Genomics Systems | 255 |
| Cytosorbents | 186 |
| Inovio Pharmaceuticals | 122 |
| Spectral AI | 78 |
| iCAD, Inc. | 69 |
| Kezar Life Sciences | 58 |
| Spero Therapeutics | 46 |
| Aileron Therapeutics | 15 |
SER News
- 11 days ago - Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - GlobeNewsWire
- 16 days ago - Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewsWire
- 24 days ago - Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - GlobeNewsWire
- 4 months ago - Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 5 months ago - Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit - GlobeNewsWire